Retatrutide 40 mg Research Reference – Draft
$340.00
Internal draft imported for compliance review. Not approved for public publication or sale.
Internal draft for compliance review. This product was imported from the Vectra peptide venture workbook and is not approved for public publication or sale.
No medical, dosing, diagnostic, treatment, or human-use claims have been added.
Workbook source: SKU Unit Econ. Launch flag: 1. Source note: Watch margin. Keep separate from 10 mg because mg drives cost and positioning.
| Attributes | Value |
|---|---|
| Molecule |
Retatrutide |
| mg per vial |
40 |
| BPW SKU |
BPW_NOLABEL_RETA_40MG_10PK_VIAL |
| Workbook launch flag |
1 |
